Saturday, July 23, 2011

Health

Steve Owens of Seattle volunteered to help test different male contraceptives and found some more to his liking than others.
Kevin P. Casey for The New York Times

Steve Owens of Seattle volunteered to help test different male contraceptives and found some more to his liking than others.

Male contraceptives are attracting growing interest from scientists, who believe they hold promise for being safe, effective and, also important, reversible.

Small-Town Doctors Made in a Small Kansas Town

As rural Kansas struggles with a shortage of doctors, a new medical school opened in Salina, with eight students who pledged to start their practices in small towns.

Your Money

Tuition Refunds, but Not Quite on Equal Terms

Sallie Mae offers tuition refund insurance policies for students who become ill and must withdraw from college, but they pay out only 75 percent if the cause is mental illness.

Recipes for Health

Yogurt Soup With Spelt, Cucumbers and Watercress

Andrew Scrivani for The New York Times

This chilled summer soup has an unusual crunchy texture.

Lawsuits and Intrigue Over 3M Diagnostic Test

A suit over a test to be marketed by 3M has escalated into a legal morass ensnaring 3M’s chief executive, Britain’s secretary of defense and a Washington lawyer.

Lilly Profit Skids as It Prepares for Patent Expirations

Despite a 11 percent drop in profit at Eli Lilly, revenue rose 9 percent and the company increased its earnings forecast.

F.D.A. Issues Alerts on the Heart Drug Multaq

The F.D.A. cautioned against using Multaq for a long-term form of atrial fibrillation.

The inventor Jonathan Rothberg with a semiconductor chip used in the Ion Torrent machine.
Christopher Capozziello for The New York Times

The inventor Jonathan Rothberg with a semiconductor chip used in the Ion Torrent machine.

The new Ion Torrent machine costs $49,000 and takes just two hours to sequence DNA, but its inventor says it will take years to make sense of much of the data it reveals.

Despite Risk, Embalmers Still Embrace Preservative

While the chemical was recently labeled a carcinogen, undertakers insist nothing else preserves the body well enough for public viewing or for shipping.

Study Links Male Infertility to a Missing Protein

The absence of a protein that coats sperm and allows them to reach an egg more easily could be the potential cause for unexplained cases of male infertility.

Consults Blog

Expert Answers on Stargardt's Disease

Dr. Stephen Rose of the Foundation Fighting Blindness responds to reader questions about Stargardt's disease.

Multimedia

Video: Gym Class: Ballet Aerobics

The Times's fitness guinea pig, Karen Barrow, tries a Figure 4 barre workout. For more Gym Class videos, go to nytimes.com/well.

Interactive Feature: Patient Voices: Macular Degeneration

How would your life be different if you couldn’t read a book, see your spouse’s face or drive? Here, six men and women speak about their lives with progressive vision loss.

From Opinion
Opinionator | Fixes

Sharing Patents to Wipe Out AIDS

The big drug maker Gilead Sciences has taken an important step in making AIDS drugs more available worldwide. But obstacles remain.

The Weekly Health Quiz

In the news: Weight gain, a presidential candidate and new Ivy League rules. Test your knowledge of this week’s health news.

Columns
Personal Health

Still Counting Calories? Your Weight-Loss Plan May Be Outdated

The most detailed long-term analysis of the factors that influence weight gain shows that conventional wisdom may not be the best approach.

Really?

The Claim: Allergies Reduce the Risk of Cancer

Danish researchers found an association between contact allergies and a decreased rate of skin and breast cancer.

Vitamins to Prevent Vision Loss

Dr. Stephen Rose of the Foundation Fighting Blindess responds to readers’ questions about nutrients and vitamins to counter macular degeneration.

Podcast: Science Times
Science Times Podcast
Subscribe

This week: The longest swim, stress and the alpha male (baboon), and treating chronic pain.

Money & Policy »

Johnson & Johnson Hurt by Recalls in Second Quarter

The company’s results also reflected flat sales in the United States and costs related to litigation and restructuring.

Times Essentials
Reporter's File

Making Sickle Cell Disease a Manageable Illness

On most days Giovanna Poli acts like a typical 12-year-old, but she is living with sickle cell disease.

The Radiation Boom

Articles in this series examine issues arising from the increasing use of medical radiation and the new technologies that deliver it.

More than 3,000 topics described, illustrated and investigated

Multimedia
Patient Voices

First-person accounts of patients' everyday challenges.

Audio Epilepsy | Alzheimer's | Migraines | Psoriasis | Alopecia | See All »

MOST POPULAR - HEALTH

Health Around the Web